Aggravation of viral hepatitis by platelet-derived serotonin
Philipp A. Lang(University Hospital of Zurich), Claudio Contaldo(University Hospital of Zurich), Panco Georgiev(University Hospital of Zurich), Ashraf Mohammad El‐Badry(University Hospital of Zurich), Mike Recher(University Hospital of Zurich), Michael Kurrer(University Hospital of Zurich), Luisa Cervantes‐Barragán(Kantonsspital St. Gallen), Burkhard Ludewig(Kantonsspital St. Gallen), Thomas Calzascia(Ontario Institute for Cancer Research), Beatrice Bolinger(Kantonsspital St. Gallen), Doron Merkler(University Hospital of Zurich), Bernhard Odermatt(University Hospital of Zurich), Michael Bäder(Max Delbrück Center), Rolf Graf(University Hospital of Zurich), Pierre A. Clavien(University Hospital of Zurich), Ahmed N. Hegazy(University Hospital of Zurich), Max Löhning(Charité - Universitätsmedizin Berlin), Nicola Harris(University Hospital of Zurich), Pamela S. Ohashi(Ontario Institute for Cancer Research), Hans Hengartner(University Hospital of Zurich), Rolf M. Zinkernagel(University Hospital of Zurich), Karl S. Lang(Ontario Institute for Cancer Research)
Cited by 234Open Access